Compare Ascendis Pharma A/S (ASND) vs Macy's Inc (M) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ascendis Pharma A/S vs Macy's Inc — how do they compare? Ascendis Pharma A/S trades at $254.5 (market cap $16.67B), while Macy's Inc trades at $24.53 (market cap $6.45B). The key difference: Ascendis Pharma A/S is far larger — about 2.6× Macy's Inc's market cap, and Macy's Inc pays a 3.12% dividend while Ascendis Pharma A/S pays none. Which is the better fit depends on your goals.
| ASND | M | |
|---|---|---|
Market Cap | $16.67B | $6.45B |
Sector | Health | Consumer Cyclical |
52-Week High | $277.18 | $26.21 |
52-Week Low | $189.74 | $12.73 |
Enterprise Value | $17.04B | $10.26B |
Dividend Yield | — | 3.12% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →About Macy's Inc
Founded in 1858 and based in New York City, Macy's operates 570 stores under the Macy's nameplate, 58 stores under the Bloomingdale's nameplate, and 160 freestanding Bluemercury specialty beauty stores (as of the end of fiscal-year 2021). Macy's also operates e-commerce sites and licenses two Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances comprised 59% of Macy's 2021 sales.
Read more on M →
